Identification of a miRNA based model to detect prognostic subgroups in patients with aggressive B-cell lymphoma

To distinguish prognostic subgroups patients with aggressive B cell lymphoma, we analyzed 800 MIRNAS’s expression with Nanostring NCounter Micna Mirna Test on cohort 228 FFPE samples of patients registered in the Ricover-60 trial and megachoep. We identify significant Mirna signatures for the overall survival (OS) (OS) and progressive free survival (PFS) with linear cox regression punished by Laso. The level of high expression of the MIR-130A-3P and MIR-423-5P shows a better prognosis, while the high level of MIR-374B-5P, MIR-590-5P, MIR-186-5P, and MIR-106B-5P-5P increases Patients’ risk level for OS.

Regarding the PFS high expression MIR-365A-5P In addition to two other MIRNAS increases the prognosis and high level of MIR374A-5P, MIR-106B-5P, and MIR-590-5P, connected with an increased risk and poor prognosis. We identified the signature of Mirna to divide patients into two different risk groups. This prognostic model can be used in risk stratification in clinical trials in the future and helps make personalized therapeutic decisions.

Comparative analysis of transcript profile, proteome, and mirna cupffer cells and monocytes

The macrophage population in most mammalian organs consists of different origin cells. The macrophage of the population comes from the erythromiseloid precursor of the wall of the egg yolk bag; Maintenance of the amount of macrophages in the postnatal ontogenesis is practically independent of the hematopoiesis bone marrow. The largest population of the population of embryonic population is found in the central nervous system (Mikroglia) and the liver (Cell Cupffer). Conversely, dermis and mucous membranes become largely colonized by monocytes of bone marrow derivatives which show clear and phenotical plasticity.

In this study, we compare cupffer cells and monocytes using immunofenotype, gene expression profiles, proteome, and microrna collections. The observed difference does not consider the macrophage of the residents’ hearts as pure m2 macrophages or the situation owned by a monocyte has a pure M1 feature. Monocytes show signs of high plasticity and sensitivity to the pattern of molecules related to pathogens (for example, high transcription rates for <i> TLR 2 </ i>, <i> 4 </ i>, <i> 7 </ i>, and <i> 8 </ i>). Conversely, the macrophage of the Heart of the population is clearly involved in the regulations of certain organ functions (nitrogen metabolism, a complementary system protein synthesis).

PMDNE: Prediction of the Mirna-Disease Association based on network embedding and network similarity analysis

Prediction of success from the Mirna-Disease Association is nontrivial for the diagnosis and prognosis of genetic diseases. There are many methods for predicting mirna and disease, but many biological data and complex, and they are often in network form. Ways to accurately use MIRNA features and biological tissue related to diseases to predict unknown associations always become a challenge. Here, we propose PMDNE, a method based on network embedding and network similarity analysis, to predict Mirna’s associations.

At PMDNE, the structure of bipartite graphics network is improved, and the generator runs randomly designed. For embedded vectors, 128 dimensions are used, and predictive accuracy increases significantly. Compared to other network embedding methods, PMDNE is comparable and competitive with the method of art conditions. The method we can solve features extraction features, reduce the dimensions of features, and increase the efficiency of predictions of mirna-disease associations. This method can also be extended to other areas for biomedical tissue predictions.

Effect of lifestyle factors on mirna expression and signal paths: reviews

The term ‘lifestyle’ includes various factors that contribute to maintenance of good health status. Increased evidence shows that lifestyle factors can affect epigenetic mechanisms, such as MIRNAS’s expression. MIRNA dysregulation can modify gene expression and molecular pathways that can cause functional changes. This review summarizes human studies that highlights that diet, physical activity, smoking consumption and alcohol can affect the Mirna engine and some biological functions.

Most Mirnas are involved in molecular lines that affect inflammation, cell cycle regulations and carcinogenesis produce onset or the development of pathological conditions. Investigating this interaction will be very important to understand the etiology of the pathological process, the potential for new care strategies and to prevent disease.

From the Mirna target network to the Mirna function: MIR-375 can regulate apoptosis and dynamics of actin in the heart muscle through the path that depends on RHO-GTPASES

Micrornas (MIRNAS) is a short ribonucleic acid molecule (RNA), without code, which is involved in the main biological process regulations, such as apoptosis or proliferation and cell differentiation, through specific interactions of sequences with the MRNAS target. In this study, we propose workflows to predict the MIRNA function by analyzing their target gene network structure. This workflow is applied to study the functional role of the MIR-375 in the heart of the muscle (myocardium), because Mirna previously proved to be associated with heart disease, and the data on its functions in myocardium was largely unclear.

Hygromycin B

AG190 1 mg
EUR 523

Hygromycin B

AT190 1mg
EUR 1114

Hygromycin B

abx082491-1g 1 g
EUR 398

Hygromycin B

abx184120-1g 1 g
EUR 300

Hygromycin B

A2515-200 200 mg
EUR 108
Description: Hygromycin B is a selective antibiotic.Antibiotics are a type of antimicrobial used in the treatment and prevention of bacterial infection.Hygromycin B is an antibiotic that is effective on most bacteria, fungi and higher eukaryotes.

Hygromycin B

A2515-5.1 10 mM (in 1mL DMSO)
EUR 108
Description: Hygromycin B is a selective antibiotic.Antibiotics are a type of antimicrobial used in the treatment and prevention of bacterial infection.Hygromycin B is an antibiotic that is effective on most bacteria, fungi and higher eukaryotes.

Hygromycin B

A2515-500 500 mg
EUR 142
Description: Hygromycin B is a selective antibiotic.Antibiotics are a type of antimicrobial used in the treatment and prevention of bacterial infection.Hygromycin B is an antibiotic that is effective on most bacteria, fungi and higher eukaryotes.

Hygromycin B

2589-1000
EUR 262

Hygromycin B

2589-500
EUR 196

Hygromycin B Concentrated

H001-1MU 1 MU
EUR 97

Hygromycin B, 10g

R3128-10g
EUR 2270

Hygromycin B, 1g

R3128-1g
EUR 302

Hygromycin B [BSA]

DAG4469 0.5mg
EUR 780

Hygromycin B [KLH]

DAG4485 0.5mg
EUR 1040

HYGROMYCIN B SOLUTION

30-240-CR 20 mL/pk
EUR 157
Description: Media Catalog; Cell Culture Reagents

EZSolution? Hygromycin B

2590-20
EUR 272

Hygromycin B EvoPure®

H010-1G 1 g
EUR 188

Hygromycin B EvoPure®

H010-500MG 500 mg
EUR 144

Hygromycin B EvoPure (Low Endotoxin)

H024-1G 1g
EUR 542

Hygromycin B EvoPure (Low Endotoxin)

H024-500MG 500 mg
EUR 346

Hygromycin B Solution (Low Endotoxin)

H026-20ML 20 mL
EUR 119

Hygromycin Antibody

abx023698-1mg 1 mg
EUR 1094

Hygromycin Antibody

abx023699-1mg 1 mg
EUR 1094

Escherichia coli Hygromycin-B 4-O-kinase (hph)

1-CSB-YP365448ENL
  • EUR 679.00
  • EUR 335.00
  • EUR 2172.00
  • EUR 1051.00
  • EUR 1442.00
  • EUR 435.00
  • 100ug
  • 10ug
  • 1MG
  • 200ug
  • 500ug
  • 50ug
Description: Recombinant Escherichia coli Hygromycin-B 4-O-kinase(hph) expressed in Yeast

Escherichia coli Hygromycin-B 4-O-kinase (hph)

1-CSB-EP365448ENL
  • EUR 611.00
  • EUR 309.00
  • EUR 1827.00
  • EUR 939.00
  • EUR 1218.00
  • EUR 397.00
  • 100ug
  • 10ug
  • 1MG
  • 200ug
  • 500ug
  • 50ug
Description: Recombinant Escherichia coli Hygromycin-B 4-O-kinase(hph) expressed in E.coli

Escherichia coli Hygromycin-B 4-O-kinase (hph)

1-CSB-EP365448ENLa0
  • EUR 611.00
  • EUR 309.00
  • EUR 1827.00
  • EUR 939.00
  • EUR 1218.00
  • EUR 397.00
  • 100ug
  • 10ug
  • 1MG
  • 200ug
  • 500ug
  • 50ug
Description: Recombinant Escherichia coli Hygromycin-B 4-O-kinase(hph) expressed in E.coli

Hygromycin phosphotransferase antibody

10-1418 1 mg
EUR 678
Description: Mouse monoclonal Hygromycin phosphotransferase antibody

Hygromycin phosphotransferase antibody

10-1419 1 mg
EUR 678
Description: Mouse monoclonal Hygromycin phosphotransferase antibody

Hygromycin phosphotransferase antibody

10-1420 1 mg
EUR 678
Description: Mouse monoclonal Hygromycin phosphotransferase antibody

Hygromycin phosphotransferase antibody

10-1421 1 mg
EUR 678
Description: Mouse monoclonal Hygromycin phosphotransferase antibody

Hygromycin B Solution (50 mg/ml in PBS Buffer)

H011-20ML 20 mL
EUR 111

Hygromycin B Solution (50 mg/ml in PBS Buffer)

H011-5x20ML 5x20mL
EUR 367

Fmoc-b,b-diphenyl-Ala-OH

B-2725.0250 250.0mg
EUR 139
Description: Sum Formula: C30H25NO4; CAS# [201484-50-6]

Fmoc-b,b-diphenyl-Ala-OH

B-2725.1000 1.0g
EUR 357
Description: Sum Formula: C30H25NO4; CAS# [201484-50-6]

Fmoc-b,b-diphenyl-Ala-OH

B-2725.5000 5.0g
EUR 1336
Description: Sum Formula: C30H25NO4; CAS# [201484-50-6]

Hygromycin B EvoPure Solution (100 mg/ml in PBS Buffer)

H015-10x2ML 10 x 2 mL
EUR 284

Hygromycin B EvoPure Solution (100 mg/ml in PBS Buffer)

H015-5x2ML 5 x 2 mL
EUR 188

Recombinant E.coli Hygromycin-B 4-O-kinase Protein, His, Yeast-100ug

QP7397-ye-100ug 100ug
EUR 788

Recombinant E.coli Hygromycin-B 4-O-kinase Protein, His, Yeast-10ug

QP7397-ye-10ug 10ug
EUR 362

Recombinant E.coli Hygromycin-B 4-O-kinase Protein, His, Yeast-1mg

QP7397-ye-1mg 1mg
EUR 2747

Recombinant E.coli Hygromycin-B 4-O-kinase Protein, His, Yeast-200ug

QP7397-ye-200ug 200ug
EUR 1260

Recombinant E.coli Hygromycin-B 4-O-kinase Protein, His, Yeast-500ug

QP7397-ye-500ug 500ug
EUR 1804

Recombinant E.coli Hygromycin-B 4-O-kinase Protein, His, Yeast-50ug

QP7397-ye-50ug 50ug
EUR 480

MEF Feeder Cells (Hygromycin-resistant)

CBA-313 1 vial
EUR 461
Description: MEF Feeder Cells are mouse embryonic fibroblasts that allow stem cell culture without LIF. Cells must be mitotically inactivated prior to addition of stem cells. Hygromycin resistant.

Fmoc-b-Ala-OH

B-1025.0005 5.0g
EUR 115
Description: Sum Formula: C18H17NO4; CAS# [35737-10-1]

Fmoc-b-Ala-OH

B-1025.0025 25.0g
EUR 236
Description: Sum Formula: C18H17NO4; CAS# [35737-10-1]

Fmoc-b-Ala-OH

B-1025.0100 100.0g
EUR 635
Description: Sum Formula: C18H17NO4; CAS# [35737-10-1]

Fmoc-b-Ala-OPfp

B-1765.0005 5.0g
EUR 236
Description: Sum Formula: C24H16F5NO4; CAS# [149303-38-8]

Fmoc-b-Ala-OPfp

B-1765.0025 25.0g
EUR 841
Description: Sum Formula: C24H16F5NO4; CAS# [149303-38-8]

Recombinant E.coli Hygromycin-B 4-O-kinase Protein, His-SUMO, E.coli-100ug

QP7397-ec-100ug 100ug
EUR 707

Recombinant E.coli Hygromycin-B 4-O-kinase Protein, His-SUMO, E.coli-10ug

QP7397-ec-10ug 10ug
EUR 326

Recombinant E.coli Hygromycin-B 4-O-kinase Protein, His-SUMO, E.coli-1mg

QP7397-ec-1mg 1mg
EUR 2303

Recombinant E.coli Hygromycin-B 4-O-kinase Protein, His-SUMO, E.coli-200ug

QP7397-ec-200ug 200ug
EUR 1115

Recombinant E.coli Hygromycin-B 4-O-kinase Protein, His-SUMO, E.coli-500ug

QP7397-ec-500ug 500ug
EUR 1514

Recombinant E.coli Hygromycin-B 4-O-kinase Protein, His-SUMO, E.coli-50ug

QP7397-ec-50ug 50ug
EUR 435

Fmoc-b-cyclohexyl-Ala-OH

B-1975.0001 1.0g
EUR 126
Description: Sum Formula: C24H27NO4; CAS# [135673-97-1]

Fmoc-b-cyclohexyl-Ala-OH

B-1975.0005 5.0g
EUR 418
Description: Sum Formula: C24H27NO4; CAS# [135673-97-1]

Fmoc-b-cyclohexyl-Ala-OH

B-1975.0025 25.0g
EUR 1192
Description: Sum Formula: C24H27NO4; CAS# [135673-97-1]

Fmoc-b-cyclopropyl-Ala-OH

B-2905.0001 1.0g
EUR 345
Description: Sum Formula: C21H21NO4; CAS# [214750-76-2]

Fmoc-b-cyclopropyl-Ala-OH

B-2905.0005 5.0g
EUR 1301
Description: Sum Formula: C21H21NO4; CAS# [214750-76-2]

Fmoc-b-(2-thienyl)-Ala-OH

B-1665.0001 1.0g
EUR 284
Description: Sum Formula: C22H19NO4S; CAS# [130309-35-2]

Fmoc-b-(2-thienyl)-Ala-OH

B-1665.0005 5.0g
EUR 1046
Description: Sum Formula: C22H19NO4S; CAS# [130309-35-2]

Fmoc-b-(3-pyridyl)-Ala-OH

B-2005.0001 1.0g
EUR 393
Description: Sum Formula: C23H20N2O4; CAS# [175453-07-3]

Fmoc-b-(3-pyridyl)-Ala-OH

B-2005.0005 5.0g
EUR 1482
Description: Sum Formula: C23H20N2O4; CAS# [175453-07-3]

Fmoc-b-cyclohexyl-D-Ala-OH

B-2345.0001 1.0g
EUR 151
Description: Sum Formula: C24H27NO4; CAS# [144701-25-7]

Fmoc-b-cyclohexyl-D-Ala-OH

B-2345.0005 5.0g
EUR 515
Description: Sum Formula: C24H27NO4; CAS# [144701-25-7]

Fmoc-b-cyclohexyl-D-Ala-OH

B-2345.0025 25.0g
EUR 1965
Description: Sum Formula: C24H27NO4; CAS# [144701-25-7]

Fmoc-b-(3-benzothienyl)-Ala-OH

B-2830.0001 1.0g
EUR 212
Description: Sum Formula: C26H21NO4S; CAS# [177966-60-8]

Fmoc-b-(3-benzothienyl)-Ala-OH

B-2830.0005 5.0g
EUR 756
Description: Sum Formula: C26H21NO4S; CAS# [177966-60-8]

Fmoc-b-cyclopropyl-D-Ala-OH

B-2915.0001 1.0g
EUR 587
Description: Sum Formula: C21H21NO4; CAS# [170642-29-2]

Fmoc-b-cyclopropyl-D-Ala-OH

B-2915.0005 5.0g
EUR 2255
Description: Sum Formula: C21H21NO4; CAS# [170642-29-2]

Fmoc-b-(2-quinolyl)-Ala-OH

B-3165.0250 250.0mg
EUR 381
Description: Sum Formula: C27H22N2O4; CAS# [214852-56-9]

Fmoc-b-(2-quinolyl)-Ala-OH

B-3165.1000 1.0g
EUR 1070
Description: Sum Formula: C27H22N2O4; CAS# [214852-56-9]

Fmoc-b-azido-Aib-OH · BHA

B-4530.0001 1.0g
EUR 705
Description: Sum Formula: C19H18N4O4·C13H13N; CAS# [1926163-90-7] net

Fmoc-b-(3-pyridyl)-D-Ala-OH

B-2040.0001 1.0g
EUR 273
Description: Sum Formula: C23H20N2O4; CAS# [142994-45-4]

Fmoc-b-(3-pyridyl)-D-Ala-OH

B-2040.0005 5.0g
EUR 998
Description: Sum Formula: C23H20N2O4; CAS# [142994-45-4]

Fmoc-b-(2-thienyl)-D-Ala-OH

B-2120.0001 1.0g
EUR 309
Description: Sum Formula: C22H19NO4S; CAS# [201532-42-5]

Fmoc-b-(2-thienyl)-D-Ala-OH

B-2120.0005 5.0g
EUR 1143
Description: Sum Formula: C22H19NO4S; CAS# [201532-42-5]

Fmoc-b-(2-quinolyl)-D-Ala-OH

B-3170.0250 250.0mg
EUR 441
Description: Sum Formula: C27H22N2O4; CAS# [214852-58-1]

Fmoc-b-(2-quinolyl)-D-Ala-OH

B-3170.1000 1.0g
EUR 1276
Description: Sum Formula: C27H22N2O4; CAS# [214852-58-1]

Fmoc-b-(3-benzothienyl)-D-Ala-OH

B-3435.0001 1.0g
EUR 334
Description: Sum Formula: C26H21NO4S; CAS# [177966-61-9]

Fmoc-b-(3-benzothienyl)-D-Ala-OH

B-3435.0005 5.0g
EUR 1240
Description: Sum Formula: C26H21NO4S; CAS# [177966-61-9]

Fmoc-b-(1-piperazinyl)-Ala(Boc)-OH

B-3725.0250 250.0mg
EUR 383
Description: Sum Formula: C27H33N3O6; CAS# [313052-20-9]

Fmoc-b-(1-piperazinyl)-Ala(Boc)-OH

B-3725.1000 1.0g
EUR 1088
Description: Sum Formula: C27H33N3O6; CAS# [313052-20-9]

Fmoc-b-azido-D-Aib-OH · BHA

B-4535.0001 1.0g
EUR 705
Description: Sum Formula: C19H18N4O4·C13H13N; CAS# [1926163-91-8] net

Fmoc-Asn(GlcNAc(Ac)3-b-D)-OH

B-2480.0100 100.0mg
EUR 587
Description: Sum Formula: C33H37N3O13; CAS# [131287-39-3]

Fmoc-Asn(GlcNAc(Ac)3-b-D)-OH

B-2480.0250 250.0mg
EUR 1143
Description: Sum Formula: C33H37N3O13; CAS# [131287-39-3]

Fmoc-N-(N-b-Boc-aminoethyl)-Gly-OH

B-3285.0001 1.0g
EUR 454
Description: Sum Formula: C24H28N2O6; CAS# [141743-15-9]

Fmoc-N-(N-b-Boc-aminoethyl)-Gly-OH

B-3285.0005 5.0g
EUR 1698
Description: Sum Formula: C24H28N2O6; CAS# [141743-15-9]

Fmoc-Ser(GlcNAc(Ac)3-b-D)-OH

B-3865.0025 25.0mg
EUR 265
Description: Sum Formula: C32H36N2O13; CAS# [160067-63-0]

Fmoc-Ser(GlcNAc(Ac)3-b-D)-OH

B-3865.0100 100.0mg
EUR 735
Description: Sum Formula: C32H36N2O13; CAS# [160067-63-0]

Fmoc-Ser(GlcNAc(Ac)3-b-D)-OH

B-3865.0250 250.0mg
EUR 1438
Description: Sum Formula: C32H36N2O13; CAS# [160067-63-0]

Fmoc-Ser(GalNAc(Ac)3-b-D)-OH

B-4235.0025 25.0mg
EUR 265
Description: Sum Formula: C32H36N2O13; CAS# [1676104-71-4]

Fmoc-Ser(GalNAc(Ac)3-b-D)-OH

B-4235.0100 100.0mg
EUR 735
Description: Sum Formula: C32H36N2O13; CAS# [1676104-71-4]

Fmoc-Ser(GalNAc(Ac)3-b-D)-OH

B-4235.0250 250.0mg
EUR 1438
Description: Sum Formula: C32H36N2O13; CAS# [1676104-71-4]

Fmoc-Thr(GalNAc(Ac)3-b-D)-OH

B-4240.0025 25.0mg
EUR 277
Description: Sum Formula: C33H38N2O13; CAS# [133575-43-6]

Fmoc-Thr(GalNAc(Ac)3-b-D)-OH

B-4240.0100 100.0mg
EUR 770
Description: Sum Formula: C33H38N2O13; CAS# [133575-43-6]

Fmoc-Thr(GalNAc(Ac)3-b-D)-OH

B-4240.0250 250.0mg
EUR 1510
Description: Sum Formula: C33H38N2O13; CAS# [133575-43-6]

Fmoc-Thr(GlcNAc(Ac)3-b-D)-OH

B-4245.0025 25.0mg
EUR 277
Description: Sum Formula: C33H38N2O13; CAS# [160168-40-1]

Fmoc-Thr(GlcNAc(Ac)3-b-D)-OH

B-4245.0100 100.0mg
EUR 770
Description: Sum Formula: C33H38N2O13; CAS# [160168-40-1]

Fmoc-Thr(GlcNAc(Ac)3-b-D)-OH

B-4245.0250 250.0mg
EUR 1510
Description: Sum Formula: C33H38N2O13; CAS# [160168-40-1]

Fmoc-b-(7-methoxy-coumarin-4-yl)-Ala-OH

B-3740.0500 500.0mg
EUR 345
Description: Sum Formula: C28H23NO7; CAS# [524698-40-6]

Fmoc-b-(7-methoxy-coumarin-4-yl)-Ala-OH

B-3740.1000 1.0g
EUR 605
Description: Sum Formula: C28H23NO7; CAS# [524698-40-6]

Hematoxylin, Weigert's Iron (Part B)

HWI-B-250 250 ml
EUR 72

Goat Anti-Protective Antigen 83 (PA83; B Anthracis) IgG-biotinylated

PA16-B 50 ug
EUR 408

ODN 1668 -Type B murine TLR9 Agonist biotin conjugate- Antigen grade

ODN1668-B Custom Ask for price

ODN 1826- Type B murine TLR9 Agonist Biotin conjugate, antigen grade

ODN1826-B Custom Ask for price

Fmoc-b-(2,2-dimethyl-4H-benzo[1,3]dioxin-6-yl)-Ala-OH

B-3310.0001 1.0g
EUR 515
Description: Sum Formula: C28H27NO6; CAS# [252049-13-1]

Fmoc-b-(2,2-dimethyl-4H-benzo[1,3]dioxin-6-yl)-Ala-OH

B-3310.0005 5.0g
EUR 1976
Description: Sum Formula: C28H27NO6; CAS# [252049-13-1]

Mouse Monoclonal Anti-Rat CD45RA/B Biotin (Clone OX-33) (mouse IgG1)

RCD045RAB-B 100 tests
EUR 469

metallo-b-lactamase inhibitor, DNA aptamer, Biotinylated

AD-159-B Custom Ask for price

ODN 2006 (CpG 7909/ODN7909) -Type B-human TLR9 agonist Biotin conjugate-antigen grade

ODN2006-B 50 ug
EUR 225

Multivalent B-cell receptor specific, DNA apatamer, Biotinylated

AD-156-B Custom Ask for price

Bovine Cyclophilin B (CYPB) ELISA Kit

RD-CYPB-b-48Tests 48 Tests
EUR 555

Bovine Cyclophilin B (CYPB) ELISA Kit

RD-CYPB-b-96Tests 96 Tests
EUR 771

Bovine Fetuin B (FETUB) ELISA Kit

RD-FETUB-b-48Tests 48 Tests
EUR 580

Bovine Fetuin B (FETUB) ELISA Kit

RD-FETUB-b-96Tests 96 Tests
EUR 807

Bovine Cyclophilin B (CYPB) ELISA Kit

DLR-CYPB-b-48T 48T
EUR 547
Description: A sandwich quantitative ELISA assay kit for detection of Bovine Cyclophilin B (CYPB) in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids.

Bovine Cyclophilin B (CYPB) ELISA Kit

DLR-CYPB-b-96T 96T
EUR 715
Description: A sandwich quantitative ELISA assay kit for detection of Bovine Cyclophilin B (CYPB) in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids.

Bovine Fetuin B (FETUB) ELISA Kit

DLR-FETUB-b-48T 48T
EUR 569
Description: A sandwich quantitative ELISA assay kit for detection of Bovine Fetuin B (FETUB) in samples from serum, plasma or other biological fluids.

Bovine Fetuin B (FETUB) ELISA Kit

DLR-FETUB-b-96T 96T
EUR 746
Description: A sandwich quantitative ELISA assay kit for detection of Bovine Fetuin B (FETUB) in samples from serum, plasma or other biological fluids.

Bovine Cyclophilin B (CYPB) ELISA Kit

RDR-CYPB-b-48Tests 48 Tests
EUR 580

Bovine Cyclophilin B (CYPB) ELISA Kit

RDR-CYPB-b-96Tests 96 Tests
EUR 807

Bovine Fetuin B (FETUB) ELISA Kit

RDR-FETUB-b-48Tests 48 Tests
EUR 607

Bovine Fetuin B (FETUB) ELISA Kit

RDR-FETUB-b-96Tests 96 Tests
EUR 845

NATtrol Influenza A/B Positive Control (6 X 0.5 mL)

NATFLUA/B-6MC 6 X 0.5 mL
EUR 232
Description: Please contact Gentaur in order to receive the datasheet of the product.

Platelet-Derived Growth Factor B-chain (36t), DNA Aptamer, Biotinylated

AD-136-B Custom Ask for price

HCV NS4 recombinant antigen NS4a+b, Biotin

00116-V-B-01mg 0,1 mg
EUR 267.5
Description: HCV NS4 recombinant antigen NS4a+b a.a 1658 to a.a 1863 of HCV polyprotein, 19 kDa. Biotin conjugate.

HCV NS4 recombinant antigen NS4a+b, Biotin

00116-V-B-1000ug 1000 ug
EUR 1282.5
Description: HCV NS4 recombinant antigen NS4a+b a.a 1658 to a.a 1863 of HCV polyprotein, 19 kDa. Biotin conjugate.

Recombinant Hepatitis C HCV NS4 a+b Protein, Biotin, E.coli-100ug

QP12178-B-100ug 100ug
EUR 318

Recombinant Hepatitis C HCV NS4 a+b Protein, Biotin, E.coli-1mg

QP12178-B-1mg 1mg
EUR 1561

Recombinant Hepatitis C HCV NS4 a+b Protein, Biotin, E.coli-500ug

QP12178-B-500ug 500ug
EUR 962

Bovine B-Cell Leukemia/Lymphoma 2 (Bcl2) ELISA Kit

RD-Bcl2-b-48Tests 48 Tests
EUR 494

Bovine B-Cell Leukemia/Lymphoma 2 (Bcl2) ELISA Kit

RD-Bcl2-b-96Tests 96 Tests
EUR 684

Bovine Vascular Endothelial Growth Factor B (VEGFB) ELISA Kit

RD-VEGFB-b-48Tests 48 Tests
EUR 494

Bovine Vascular Endothelial Growth Factor B (VEGFB) ELISA Kit

RD-VEGFB-b-96Tests 96 Tests
EUR 684

Bovine Vascular Endothelial Growth Factor B (VEGFB) ELISA Kit

DLR-VEGFB-b-48T 48T
EUR 493
Description: A sandwich quantitative ELISA assay kit for detection of Bovine Vascular Endothelial Growth Factor B (VEGFB) in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids.

Bovine Vascular Endothelial Growth Factor B (VEGFB) ELISA Kit

DLR-VEGFB-b-96T 96T
EUR 641
Description: A sandwich quantitative ELISA assay kit for detection of Bovine Vascular Endothelial Growth Factor B (VEGFB) in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids.

Bovine B-Cell Leukemia/Lymphoma 2 (Bcl2) ELISA Kit

DLR-Bcl2-b-48T 48T
EUR 493
Description: A sandwich quantitative ELISA assay kit for detection of Bovine B-Cell Leukemia/Lymphoma 2 (Bcl2) in samples from serum, plasma, tissue homogenates or other biological fluids.

Bovine B-Cell Leukemia/Lymphoma 2 (Bcl2) ELISA Kit

DLR-Bcl2-b-96T 96T
EUR 641
Description: A sandwich quantitative ELISA assay kit for detection of Bovine B-Cell Leukemia/Lymphoma 2 (Bcl2) in samples from serum, plasma, tissue homogenates or other biological fluids.

Bovine Vascular Endothelial Growth Factor B (VEGFB) ELISA Kit

RDR-VEGFB-b-48Tests 48 Tests
EUR 516

Bovine Vascular Endothelial Growth Factor B (VEGFB) ELISA Kit

RDR-VEGFB-b-96Tests 96 Tests
EUR 716

Bovine B-Cell Leukemia/Lymphoma 2 (Bcl2) ELISA Kit

RDR-Bcl2-b-48Tests 48 Tests
EUR 516

Bovine B-Cell Leukemia/Lymphoma 2 (Bcl2) ELISA Kit

RDR-Bcl2-b-96Tests 96 Tests
EUR 716

Hepatitis B Surface Antigen (HBsAg) pre-S1 peptide-Biotin (2-48-aa, >90%, ~5.5 kda)

HBVS16-B-100 100 ug
EUR 347

Myristoylated-Hepatitis B Surface Antigen (HBsAg) pre-S1 peptide-Biotin (2-48-aa, >90%, ~5.7 kda)

HBVS17-B-100 100 ug
EUR 408

NPR-B/GC-B/ Rat NPR- B/ GC- B ELISA Kit

ELA-E14914r 96 Tests
EUR 886

H-b-Ala-b-Ala-b-Ala-OH

H-1250.0250 250.0mg
EUR 297
Description: Sum Formula: C9H17N3O4; CAS# [69010-59-9]

H-b-Ala-b-Ala-b-Ala-OH

H-1250.1000 1.0g
EUR 828
Description: Sum Formula: C9H17N3O4; CAS# [69010-59-9]

Aurora B (Aurora B) Antibody

abx038410-100ug 100 ug
EUR 391

Influenza B (B / Malaysia) Protein

abx060631-1mg 1 mg
EUR 1873

Aurora B (Aurora B) Antibody

abx037697-100ug 100 ug
EUR 391

Aurora B (Aurora B) Antibody

20-abx133082
  • EUR 300.00
  • EUR 439.00
  • EUR 189.00
  • 100 ul
  • 200 ul
  • 30 ul

Cyclophilin B (Cyclophilin-B) Antibody

20-abx137287
  • EUR 704.00
  • EUR 328.00
  • EUR 230.00
  • 100 ug
  • 20 ug
  • 5 ug

UT-B (UT-B) Antibody

abx239345-100ug 100 ug
EUR 509

LC3A/B (LC3A/B) Antibody

abx234718-100ug 100 ug
EUR 551

We identify PIK3CA, RHOA, MAPK3, PAFAY1B1, CTNNB1, MYC, PRKCA, ERBB2, and CDC42 as a key gene on the MIR-375 network which is set and estimates the possible function of the MIR-375 in the heart muscle, which consists mainly in regulations on signaling paths that are dependent on on RHO-GTPases. We apply our algorithm to predict Mirna’s function into the python module, which is available at GitHub.

Leave A Comment